Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy.
Journal of internal medicine 2012 May 271 (5): 499-509.
Huang C-N, Huang S-P, Pao J-B, Hour T-C, Chang T-Y, Lan Y-H, Lu T-L, Lee H-Z, Juang S-H, Wu P-P, Huang C-Y, Hsieh C-J, Bao B
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: